Australian pharmaceutical distributor Sigma Healthcare announced it is engaged in preliminary discussions regarding a potential acquisition of Boots, the prominent UK drugstore chain.

The talks are described as being in early stages, with no certainty that any transaction will materialize. Sigma Healthcare disclosed the discussions in accordance with market disclosure requirements, though specific financial terms or deal structure details were not provided.

Boots operates one of the UK's largest pharmacy and health retail networks, with hundreds of locations across the country offering prescription services, health products, and beauty items. The chain has been a fixture of British retail for over a century.

Sigma Healthcare is primarily known as a pharmaceutical wholesaler and distributor in Australia, supplying medicines and healthcare products to pharmacies and other healthcare providers. An acquisition of Boots would represent a significant international expansion for the Australian company.

Both companies emphasized that the discussions are preliminary and cautioned that there is no guarantee the talks will lead to any formal offer or completed transaction.